share_log

XOMA Royalty Shares Are Trading Higher After the Company Announced Its Economic Interest in Seralutinib, a Phase 3 Asset Studying Pulmonary Arterial Hypertension.

Benzinga ·  Dec 2 21:39
XOMA Royalty Shares Are Trading Higher After the Company Announced Its Economic Interest in Seralutinib, a Phase 3 Asset Studying Pulmonary Arterial Hypertension.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment